+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Photodynamic Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911344
  • Report
  • November 2019
  • Region: Global
  • 243 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Biofrontera AG
  • LUMIBIRD
  • Modulight, Inc.
  • Quest PharmaTech Inc.
Photodynamic Therapy Market - Scope of the Report

the report on the global photodynamic therapy market studies the past as well as current growth trends and opportunities to gain valuable insights for the said market during the forecast period, i.e. from 2019 to 2027. The report provides the overall market revenue of the global photodynamic therapy market for the 2017 - 2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global photodynamic therapy market for the same period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts have conducted interviews with market leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global photodynamic therapy market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches, to study various phenomena in the global photodynamic therapy market.

The report includes an elaborate executive summary along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global photodynamic therapy market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global photodynamic therapy market. The next section of the report highlights the USPs, which include epidemiology of skin disorders, regulatory scenario assessment, technological advancements, major diseases treated by photodynamic therapy such as cancer, patent landscape summary, and list of major companies operating in the global photodynamic therapy market.

The report delves into the competition landscape of the global photodynamic therapy market. Key players operating in the global photodynamic therapy market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global photodynamic therapy market profiled in this report.

Key Questions Answered in Report on Global Photodynamic Therapy Market

  • What are the major driving factors, restraining factors, opportunities for the global photodynamic therapy market?
  • What would be the revenue share projection of key segments of the global photodynamic therapy market during the forecast period?
  • Which segment is likely to lead the global photodynamic therapy market in terms of revenue from 2019 and 2027?
  • How mergers and acquisitions among players are widening the scope for the global photodynamic therapy market?
  • What is the market position of different companies operating in the global photodynamic therapy market?

Global Photodynamic Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global photodynamic therapy market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global photodynamic therapy market. It is followed by market introduction, market dynamics, and an overview of the global photodynamic therapy market, which includes an’s analysis of the market drivers, restraints, and trends pertaining to the global photodynamic therapy market. Furthermore, in order to understand the Y-o-Y growth trend of the global photodynamic therapy market, Y-o-Y growth analysis with elaborated insights on the same have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biofrontera AG
  • LUMIBIRD
  • Modulight, Inc.
  • Quest PharmaTech Inc.

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Epidemiology of Skin Disorders and Cancer
5.2. Major Companies in Global Photodynamic Therapy Market
5.3. Regulatory Scenario Assessment
5.4. Technological Advancements
5.5. Major Diseases Treated through Photodynamic Therapy
5.6. Patent Landscape Summary
6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
6.2.1. Drugs
6.2.1.1. Porphyrin Derivative (PD)
6.2.1.1.1. Hematoporphyrin Derivative (HpD)
6.2.1.1.2. Benzoporphyrin Derivative (BPD)
6.2.1.1.3. Texaphyrins
6.2.1.1.4. Others
6.2.1.2. Aminolevulinic acid (ALA)
6.2.1.3. Chlorines
6.2.1.4. Others
6.2.2. Devices
6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
6.2.2.2. Diode Laser
6.3. Global Photodynamic Therapy Market Attractiveness, by Product
7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application
7.1. Introduction
7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
7.2.1. Cancer
7.2.1.1. Basal Cell Carcinoma
7.2.1.2. Non-small Cell Lung Cancer
7.2.1.3. Head & Neck Cancer
7.2.1.4. Others
7.2.2. Actinic Keratosis (AK)
7.2.3. Psoriasis
7.2.4. Acne
7.2.5. Others
7.3. Global Photodynamic Therapy Market Attractiveness, by Application
8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user
8.1. Introduction
8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
8.2.1. Hospitals
8.2.2. Cosmetics & Dermatology Clinics
8.2.3. Cancer Treatment Centers
8.2.4. Others
8.3. Global Photodynamic Therapy Market Attractiveness, by End-user
9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region
9.1. Introduction
9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Photodynamic Therapy Market Attractiveness, by Region
10. North America Photodynamic Therapy Market Analysis and Forecast
10.1. Introduction
10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
10.2.1. Drugs
10.2.1.1. Porphyrin Derivative (PD)
10.2.1.1.1. Hematoporphyrin Derivative (HpD)
10.2.1.1.2. Benzoporphyrin Derivative (BPD)
10.2.1.1.3. Texaphyrins
10.2.1.1.4. Others
10.2.1.2. Aminolevulinic Acid (ALA)
10.2.1.3. Chlorines
10.2.1.4. Others
10.2.2. Devices
10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
10.2.2.2. Diode Laser
10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
10.3.1. Cancer
10.3.1.1. Basal Cell Carcinoma
10.3.1.2. Non-small Cell Lung Cancer
10.3.1.3. Head & Neck Cancer
10.3.1.4. Others
10.3.2. Actinic Keratosis (AK)
10.3.3. Psoriasis
10.3.4. Acne
10.3.5. Others
10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Cosmetics & Dermatology Clinics
10.4.3. Cancer Treatment Centers
10.4.4. Others
10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Photodynamic Therapy Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
11.2.1. Drugs
11.2.1.1. Porphyrin Derivative (PD)
11.2.1.1.1. Hematoporphyrin Derivative (HpD)
11.2.1.1.2. Benzoporphyrin Derivative (BPD)
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulinic Acid (ALA)
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
11.2.2.2. Diode Laser
11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
11.3.1. Cancer
11.3.1.1. Basal Cell Carcinoma
11.3.1.2. Non-small Cell Lung Cancer
11.3.1.3. Head & Neck Cancer
11.3.1.4. Others
11.3.2. Actinic Keratosis (AK)
11.3.3. Psoriasis
11.3.4. Acne
11.3.5. Others
11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Cosmetics & Dermatology Clinics
11.4.3. Cancer Treatment Centers
11.4.4. Others
11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Photodynamic Therapy Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
12.2.1. Drugs
12.2.1.1. Porphyrin Derivative (PD)
12.2.1.1.1. Hematoporphyrin Derivative (HpD)
12.2.1.1.2. Benzoporphyrin Derivative (BPD)
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulinic Acid (ALA)
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
12.2.2.2. Diode Laser
12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
12.3.1. Cancer
12.3.1.1. Basal Cell Carcinoma
12.3.1.2. Non-small Cell Lung Cancer
12.3.1.3. Head & Neck Cancer
12.3.1.4. Others
12.3.2. Actinic Keratosis (AK)
12.3.3. Psoriasis
12.3.4. Acne
12.3.5. Others
12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Cosmetics & Dermatology Clinics
12.4.3. Cancer Treatment Centers
12.4.4. Others
12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
13.2.1. Drugs
13.2.1.1. Porphyrin Derivative (PD)
13.2.1.1.1. Hematoporphyrin Derivative (HpD)
13.2.1.1.2. Benzoporphyrin Derivative (BPD)
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulinic Acid (ALA)
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
13.2.2.2. Diode Laser
13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
13.3.1. Cancer
13.3.1.1. Basal Cell Carcinoma
13.3.1.2. Non-small Cell Lung Cancer
13.3.1.3. Head & Neck Cancer
13.3.1.4. Others
13.3.2. Actinic Keratosis (AK)
13.3.3. Psoriasis
13.3.4. Acne
13.3.5. Others
13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Cosmetics & Dermatology Clinics
13.4.3. Cancer Treatment Centers
13.4.4. Others
13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027
14.2.1. Drugs
14.2.1.1. Porphyrin Derivative (PD)
14.2.1.1.1. Hematoporphyrin Derivative (HpD)
14.2.1.1.2. Benzoporphyrin Derivative (BPD)
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulinic Acid (ALA)
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
14.2.2.2. Diode Laser
14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027
14.3.1. Cancer
14.3.1.1. Basal Cell Carcinoma
14.3.1.2. Non-small Cell Lung Cancer
14.3.1.3. Head & Neck Cancer
14.3.1.4. Others
14.3.2. Actinic Keratosis (AK)
14.3.3. Psoriasis
14.3.4. Acne
14.3.5. Others
14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Cosmetics & Dermatology Clinics
14.4.3. Cancer Treatment Centers
14.4.4. Others
14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)
15.2. Company Profiles
15.2.1. Biofrontera AG
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Theralase Technologies Inc.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. LUMIBIRD
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Quest PharmaTech Inc.
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Modulight, Inc.
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Galderma Laboratories L.P. (Nestlé)
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Sun Pharmaceutical Industries Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. Financial Overview
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. SUS Advancing Technology Co., Ltd
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Biofrontera AG
  • Theralase Technologies Inc.
  • LUMIBIRD
  • Quest PharmaTech Inc.
  • Modulight, Inc.
  • Galderma Laboratories L.P. (Nestlé)
  • Sun Pharmaceutical Industries Ltd.
  • SUS Advancing Technology Co., Ltd
Note: Product cover images may vary from those shown